International scholars share inspiring stories of their journeys to Imperial
Smart systems keep water and power flowing in Cyprus
Novel inhalable gene therapy trialled for people with cystic fibrosis
Research within the Centre works across ten different disease areas. Learn more about the work on each disease below:
All output from the Imperial College COVID-19 Response Team, including publicly published online reports, planning tools, scientific resources, publications and video updates are made available here.
Find out more
Using a range of methods to research the epidemiology and transmission of sexually transmitted infections, hepatitis and HIV.
An interdisciplinary group of researchers with an interest in developing models to inform public health decision-making
Research into tuberculosis control demands, from basic science to more policy-focused research.
Developing the best available statistical and epidemic models of influenza by gathering primary data, leveraging routine surveillance and conducting secondary analyses.
Elucidating the demographic and climatic drivers of transmission, characterising spatiotemporal heterogeneity in transmission intensity and understanding patterns of disease persistence.
Using statistical and mathematical models to understand transmission dynamics and identify optimal control and treatment strategies for NTDs.
We work on a number of enteric pathogens, including poliovirus, rotavirus, enteroviruses, typhoid, Clostridium difficile and Campylobacter. Current research is focused on methods to analyse next-generation sequencing data and to model the spread of antimicrobial resistance.
Our work aims to make the best use of the recent explosion of bacterial genome data. We are at the forefront of the development of new generally applicable statistical and computational tools to exploit genomic sequencing data in the fight against bacterial pathogens
We study emerging fungal infections by using an evolutionary framework to determine the biological and environmental factors that are driving epidemics and epizootics of novel fungal disease across human, wildlife and plant species
